Neuroinflammation in the pathogenesis of Alzheimer's disease. A rational framework for the search of novel therapeutic approaches

Frontiers in Cellular Neuroscience

Volumn 8, Issue 1 APR, 2014, Pages

  Morales, Inelia ^a,b   Guzmán Martínez, Leonardo ^a,b   Cerda Troncoso, Cristóbal ^a,b   Farías, Gonzalo A ^a,b   Maccioni, Ricardo B ^a,b  

^a UNIVERSITY OF CHILE   (Chile)

^b International Center for Biomedicine ICC   (Chile)

Author keywords

Alzheimer disease; Astrocytes; Microglia; Neuroinflammation; Nutraceuticals

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; CEREBROLYSIN; CYTOKINE; GINKGO BILOBA EXTRACT; NONSTEROID ANTIINFLAMMATORY AGENT; RESVERATROL;

ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; CONCEPTUAL FRAMEWORK; EXCITOTOXICITY; HUMAN; IMMUNOMODULATION; INNATE IMMUNITY; MICROGLIA; NERVE CELL PLASTICITY; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NONHUMAN;

EID: 84899141023     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00112     Document Type: Article

References (84)

1. Aggarwal, B. B., and Harikumar, K. B. (2009). Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int. J. Biochem. Cell Biol. 41, 40-59. doi: 10. 1016/j. biocel. 2008. 06. 010.
2. Akiyama, H., Barger, S., Barnum, S., Bradt, B., Bauer, J., Cole, G. M., et al. (2000). Inflammation and Alzheimer's disease. Neurobiol. Aging 21, 383-421. doi: 10. 1016/S0197-4580(00)00124-X.
3. Álvarez, X., and Fuentes, P. (2011). Cerebrolysin in Alzheimer's disease. Drugs Today (Barc) 47, 487-513. doi: 10. 1358/dot. 2011. 47. 7. 1656496.
4. Barres, B. A. (2008). The mystery and magic of glia: a perspective on their roles in health and disease. Neuron 60, 430-440. doi: 10. 1016/j. neuron. 2008. 10. 013.
5. Cambiazo, V., Gonzalez, M., and Maccioni, R. B. (1995). DMAP-85: a tau-like protein from Drosophila melanogaster larvae. J. Neurochem. 64, 1288-1297. doi: 10. 1046/j. 1471-4159. 1995. 64031288. x.
6. Canevelli, M., Adali, N., Kelaiditi, E., Cantet, C., Ousset, P. J., Cesari, M., and ICTUS/DSA Group. (2014). Effects of Gingko biloba supplementation in Alzheimer's disease patients receiving cholinesterase inhibitors: data from the ICTUS study. Phytomedicine doi: 10. 1016/j. phymed. 2014. 01. 003. [Epub ahead of print].
7. Carrasco-Gallardo, C., Farias, G. A., Fuentes, P., Crespo, F., and Maccioni, R. B. (2012a). Can nutraceuticals prevent Alzheimer's disease? Potential therapeutic role of a formulation containing shilajit and complex B vitamins. Arch. Med. Res. 43, 699-704. doi: 10. 1016/j. arcmed. 2012. 10. 010.
8. Carrasco-Gallardo, C., Guzman, L., and Maccioni, R. B. (2012b). Shilajit: a natural phytocomplex with potential procognitive activity. Int. J. Alzheimers Dis. 2012: 674142. doi: 10. 1155/2012/674142.
9. Casper, D., Yaparpalvi, U., Rempel, N., and Werner, P. (2000). Ibuprofen protects dopaminergic neurons against glutamate toxicity in vitro. Neurosci. Lett. 289, 201-204. doi: 10. 1016/s0304-3940(00)01294-5.
10. Chaboub, L. S., and Deneen, B. (2013). Astrocyte form and function in the developing central nervous system. Semin. Pediatr. Neurol. 20, 230-235. doi: 10. 1016/j. spen. 2013. 10. 003.
11. Choi, S. H., Aid, S., Caracciolo, L., Minami, S. S., Niikura, T., Matsuoka, Y., et al. (2013). Cyclooxygenase-1 inhibition reduces amyloid pathology and improves memory deficits in a mouse model of Alzheimer's disease. J. Neurochem. 124, 59-68. doi: 10. 1111/jnc. 12059.
12. Christopherson, K. S., Ullian, E. M., Stokes, C. C., Mullowney, C. E., Hell, J. W., Agah, A., et al. (2005). Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell 120, 421-433. doi: 10. 1016/j. cell. 2004. 12. 020.
13. Citron, M. (2010). Alzheimer's disease: strategies for disease modification. Nat. Rev. Drug Discov. 9, 387-398. doi: 10. 1038/nrd2896.
14. Colton, C., and Wilcock, D. M. (2010). Assessing activation states in microglia. CNS Neurol. Disord. Drug Targets 9, 174-191. doi: 10. 2174/187152710791012053.
15. Cornejo, A., Jimenez, J. M., Caballero, L., Melo, F., and Maccioni, R. B. (2011). Fulvic acid inhibits aggregation and promotes disassembly of tau fibrils associated with Alzheimer's disease. J. Alzheimers Dis. 27, 143-153. doi: 10. 3233/JAD-2011-110623.
16. Fernández, J. A., Rojo, L., Kuljis, R. O., and Maccioni, R. B. (2008). The damage signals hypothesis of Alzheimer's disease pathogenesis. J. Alzheimers Dis. 14, 329-333.
17. Ferrari, C. C., Pott Godoy, M. C., Tarelli, R., Chertoff, M., Depino, A. M., and Pitossi, F. J. (2006). Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1beta in the substantia nigra. Neurobiol. Dis. 24, 183-193. doi: 10. 1016/j. nbd. 2006. 06. 013.
18. Frank-Cannon, T. C., Alto, L. T., McAlpine, F. E., and Tansey, M. G. (2009). Does neuroinflammation fan the flame in neurodegenerative diseases? Mol. Neurodegener. 4: 47. doi: 10. 1186/1750-1326-4-47.
19. Giannakopoulos, P., Herrmann, F. R., Bussiere, T., Bouras, C., Kovari, E., Perl, D. P., et al. (2003). Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Neurology 60, 1495-1500. doi: 10. 1212/01. wnl. 0000063311. 58879. 01.
20. Ginhoux, F., Lim, S., Hoeffel, G., Low, D., and Huber, T. (2013). Origin and differentiation of microglia. Front. Cell. Neurosci. 7: 45. doi: 10. 3389/fncel. 2013. 00045.
21. Ha, S. K., Moon, E., Lee, P., Ryu, J. H., Oh, M. S., and Kim, S. Y. (2012). Acacetin attenuates neuroinflammation via regulation the response to LPS stimuli in vitro and in vivo. Neurochem. Res. 37, 1560-1567. doi: 10. 1007/s11064-012-0751-z.
22. Hanisch, U. K., and Kettenmann, H. (2007). Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10, 1387-1394. doi: 10. 1038/nn1997.
23. Hardy, J., and Selkoe, D. J. (2002). The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356. doi: 10. 1126/science. 1072994.
24. Harms, A. S., Cao, S., Rowse, A. L., Thome, A. D., Li, X., Mangieri, L. R., et al. (2013). MHCII is required for α-synuclein-induced activation of microglia, CD4 T cell proliferation and dopaminergic neurodegeneration. J. Neurosci. 33, 9592-9600. doi: 10. 1523/JNEUROSCI. 5610-12. 2013.
25. Heneka, M. T., Sastre, M., Dumitrescu-Ozimek, L., Hanke, A., Dewachter, I., Kuiperi, C., et al. (2005). Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice. Brain 128, 1442-1453. doi: 10. 1093/brain/awh452.
26. Hoppe, J. B., Haag, M., Whalley, B. J., Salbego, C. G., and Cimarosti, H. (2013). Curcumin protects organotypic hippocampal slice cultures from Abet-a142-induced synaptic toxicity. Toxicol. In Vitro 27, 2325-2330. doi: 10. 1016/j. tiv. 2013. 10. 002.
27. Hsiao, H. Y., Chen, Y. C., Chen, H. M., Tu, P. H., and Chern, Y. (2013). A critical role of astrocyte-mediated nuclear factor-κB-dependent inflammation in Huntington's disease. Hum. Mol. Genet. 22, 1826-1842. doi: 10. 1093/hmg/ddt036.
28. Jantzen, P. T., Connor, K. E., DiCarlo, G., Wenk, G. L., Wallace, J. L., Rojiani, A. M., et al. (2002). Microglial activation and beta-amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice. J. Neurosci. 15, 2246-2254.
29. Kang, S. S., Cuendet, M., Endringer, D. C., Croy, V. L., Pezzuto, J. M., and Lipton, M. A. (2009). Synthesis and biological evaluation of a library of resveratrol analogues as inhibitors of COX-1, COX-2 and NF-kappaB. Bioorg. Med. Chem. 17, 1044-1054. doi: 10. 1016/j. bmc. 2008. 04. 031.
30. Kassa, R. M., Mariotti, R., Bonaconsa, M., Bertini, G., and Bentivoglio, M. (2009). Gene, cell and axon changes in the familial amyotrophic lateral sclerosis mouse sensorimotor cortex. J. Neuropathol. Exp. Neurol. 68, 59-72. doi: 10. 1097/NEN. 0b013e3181922572.
31. Kim, S. J., Son, T. G., Park, H. R., Park, M., Kim, M. S., Kim, H. S., et al. (2008). Curcumin stimulates proliferation of embryonic neural progenitor cells and neurogenesis in the adult hippocampus. J. Biol. Chem. 283, 14497-14505. doi: 10. 1074/jbc. M708373200.
32. Krasowska-Zoladek, A., Banaszewska, M., Kraszpulski, M., and Konat, G. W. (2007). Kinetics of inflammatory response of astrocytes induced by TLR3 and TLR4 ligation. J. Neurosci. Res. 85, 205-212. doi: 10. 1002/jnr. 21088.
33. Kukar, T., Murphy, M. P., Eriksen, J. L., Sagi, S. A., Weggen, S., Smith, T. E., et al. (2005). Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production. Nat. Med. 11, 545-550. doi: 10. 1038/nm1235.
34. Lawson, L. J., Perry, V. H., Dri, P., and Gordon, S. (1990). Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39, 151-170. doi: 10. 1016/0306-4522(90)90229-w.
35. Leoutsakos, J. M., Muthen, B. O., Breitner, J. C., Lyketsos, C. G., and ADAPT Research Team. (2012). Effects of non-steroidal anti-inflammatory drug treatments on cognitive decline vary by phase of pre-clinical Alzheimer disease: findings from the randomized controlled Alzheimer's disease Anti-inflammatory Prevention Trial. Int. J. Geriatr. Psychiatry 27, 364-374. doi: 10. 1002/gps. 2723.
36. Li, L., Lu, J., Tay, S. S., Moochhala, S. M., and He, B. P. (2007). The function of microglia, either neuroprotection or neurotoxicity, is determined by the equilibrium among factors released from activated microglia in vitro. Brain Res. 1159, 8-17. doi: 10. 1016/j. brainres. 2007. 04. 066.
37. Lim, D., Iyer, A., Ronco, V., Grolla, A. A., Canonico, P. L., Aronica, E., et al. (2013). Amyloid beta deregulates astroglial mGluR5-mediated calcium signaling via calcineurin and Nf-kB. Glia 61, 1134-1145. doi: 10. 1002/glia. 22502.
38. Lim, G. P., Yang, F., Chu, T., Chen, P., Beech, W., Teter, B., et al. (2000). Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J. Neurosci. 20, 5709-5714.
39. 1-42) aggregation inhibitors, antioxidants and neuroprotective agents. Bioorg. Med. Chem. Lett. 22, 7683-7687. doi: 10. 1016/j. bmcl. 2012. 09. 105.
40. Lu, Z., Shen, Y., Wang, T., Cui, M., Wang, Z., Zhao, H., et al. (2014). Curcumin promotes neurite outgrowth via reggie-1/flotillin-2 in cortical neurons. Neurosci. Lett. 559, 7-12. doi: 10. 1016/j. neulet. 2013. 11. 029.
41. Maccioni, R. B. (2011). Tau protein in Alzheimer's disease. Curr. Alzheimer Res. 8, 607. doi: 10. 2174/156720511796717159.
42. Maccioni, R. B., Rojo, L. E., Fernandez, J. A., and Kuljis, R. O. (2009). The role of neuroimmunomodulation in Alzheimer's disease. Ann. N Y Acad. Sci. 1153, 240-246. doi: 10. 1111/j. 1749-6632. 2008. 03972. x.
43. Magistretti, P. J. (2009). Role of glutamate in neuron-glia metabolic coupling. Am. J. Clin. Nutr. 90, 875S-880S. doi: 10. 3945/ajcn. 2009. 27462CC.
44. Matyash, V., and Kettenmann, H. (2009). Heterogeneity in astrocyte morphology and physiology. Brain Res. Rev. 63, 2-10. doi: 10. 1016/j. brainresrev. 2009. 12. 001.
45. McGeer, P. L., and McGeer, E. G. (2007). NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies. Neurobiol. Aging 28, 639-647. doi: 10. 1016/j. neurobiolaging. 2006. 03. 013.
46. McGeer, P. L., Rogers, J., and McGeer, E. G. (2006). Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years. J. Alzheimers Dis. 9(Suppl. 3), 271-276.
47. McGeer, P. L., Schulzer, M., and McGeer, E. G. (1996). Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 47, 425-432. doi: 10. 1212/wnl. 47. 2. 425.
48. Meeuwsen, S., Persoon-Deen, C., Bsibsi, M., Ravid, R., and van Noort, J. M. (2003). Cytokine, chemokine and growth factor gene profiling of cultured human astrocytes after exposure to proinflammatory stimuli. Glia 43, 243-253. doi: 10. 1002/glia. 10259.
49. Morales, I., Farias, G., and Maccioni, R. B. (2010). Neuroimmunomodulation in the pathogenesis of Alzheimer's disease. Neuroimmunomodulation 17, 202-204. doi: 10. 1159/000258724.
50. Morales, I., Jimenez, J. M., Mancilla, M., and Maccioni, R. B. (2013). Tau oligomers and fibrils induce activation of microglial cells. J. Alzheimers Dis. 37, 849-856. doi: 10. 3233/JAD-131843.
51. Mrak, R. E. (2009). Neuropathology and the neuroinflammation idea. J. Alzheimers Dis. 18, 473-481. doi: 10. 3233/JAD-2009-1158.
52. Neumann, K., Farias, G., Slachevsky, A., Perez, P., and Maccioni, R. B. (2011). Human platelets tau: a potential peripheral marker for Alzheimer's disease. J. Alzheimers Dis. 25, 103-109. doi: 10. 3233/JAD-2011-101641.
53. Nimmerjahn, A., Kirchhoff, F., and Helmchen, F. (2005). Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308, 1314-1318. doi: 10. 1126/science. 1110647.
54. Okabe, Y., Takahashi, T., Mitsumasu, C., Kosai, K., Tanaka, E., and Matsuishi, T. (2012). Alterations of gene expression and glutamate clearance in astrocytes derived from an MeCP2-null mouse model of Rett syndrome. PLoS One 7: e35354. doi: 10. 1371/journal. pone. 0035354.
55. Olson, J. K., and Miller, S. D. (2004). Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol. 173, 3916-3924.
56. Perry, V. H. (1998). A revised view of the central nervous system microenvironment and major histocompatibility complex class II antigen presentation. J. Neuroimmunol. 90, 113-121. doi: 10. 1016/s0165-5728(98)00145-3.
57. Perry, V. H., Nicoll, J. A., and Holmes, C. (2010). Microglia in neurodegenerative disease. Nat. Rev. Neurol. 6, 193-201. doi: 10. 1038/nrneurol. 2010. 17.
58. Pfrieger, F. W., and Barres, B. A. (1997). Synaptic efficacy enhanced by glial cells in vitro. Science 277, 1684-1687. doi: 10. 1126/science. 277. 5332. 1684.
59. Powell, E. M., and Geller, H. M. (1999). Dissection of astrocyte-mediated cues in neuronal guidance and process extension. Glia 26, 73-83. doi: 10. 1002/(sici)1098-1136(199903)26: 1<73:: aid-glia8>3. 0. co; 2-s.
60. Rich, J. B., Rasmusson, D. X., Folstein, M. F., Carson, K. A., Kawas, C., and Brandt, J. (1995). Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology 45, 51-55. doi: 10. 1212/WNL. 45. 1. 51.
61. Risher, W. C., and Eroglu, C. (2012). Thrombospondins as key regulators of synaptogenesis in the central nervous system. Matrix Biol. 31, 170-177. doi: 10. 1016/j. matbio. 2012. 01. 004.
62. Rockenstein, E., Torrance, M., Mante, M., Adame, A., Paulino, A., Rose, J. B., et al. (2006). Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease. J. Neurosci. Res. 83, 1252-1261. doi: 10. 1002/jnr. 20818.
63. Shastri, A., Bonifati, D. M., and Kishore, U. (2013). Innate immunity and neuroinflammation. Mediators Inflamm. 2013: 342931. doi: 10. 1155/2013/342931.
64. Sierra, A., Encinas, J. M., Deudero, J. J., Chancey, J. H., Enikolopov, G., Overstreet-Wadiche, L. S., et al. (2010). Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis. Cell Stem Cell 7, 483-495. doi: 10. 1016/j. stem. 2010. 08. 014.
65. Simpson, J. E., Ince, P. G., Lace, G., Forster, G., Shaw, P. J., Matthews, F., et al. (2010). Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain. Neurobiol. Aging 31, 578-590. doi: 10. 1016/j. neurobiolaging. 2008. 05. 015.
66. Spittaels, K., Van den Haute, C., Van Dorpe, J., Bruynseels, K., Vandezande, K., Laenen, I., et al. (1999). Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. Am. J. Pathol. 155, 2153-2165. doi: 10. 1016/S0002-9440(10)65533-2.
67. Streit, W. J., Mrak, R. E., and Griffin, W. S. (2004). Microglia and neuroinflammation: a pathological perspective. J. Neuroinflammation 1: 14. doi: 10. 1186/1742-2094-1-14.
68. Szekely, C. A., Thorne, J. E., Zandi, P. P., Ek, M., Messias, E., Breitner, J. C., et al. (2004). Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review. Neuroepidemiology 23, 159-169. doi: 10. 1159/000078501.
69. Tower, D. B., and Young, O. M. (1973). The activities of butyrylcholinesterase and carbonic anhydrase, the rate of anaerobic glycolysis and the question of a constant density of glial cells in cerebral cortices of various mammalian species from mouse to whale. J. Neurochem. 20, 269-278. doi: 10. 1111/j. 1471-4159. 1973. tb12126. x.
70. Town, T. (2010). Inflammation, immunity and Alzheimer's disease. CNS Neurol. Disord. Drug Targets 9, 129-131. doi: 10. 2174/187152710791012008.
71. Ullian, E. M., Sapperstein, S. K., Christopherson, K. S., and Barres, B. A. (2001). Control of synapse number by glia. Science 291, 657-661. doi: 10. 1126/science. 291. 5504. 657.
72. van Kralingen, C., Kho, D. T., Costa, J., Angel, C. E., and Graham, E. S. (2013). Exposure to inflammatory cytokines IL-1beta and TNFalpha induces compromise and death of astrocytes; implications for chronic neuroinflammation. PLoS One 8: e84269. doi: 10. 1371/journal. pone. 0084269.
73. Varvel, N. H., Bhaskar, K., Kounnas, M. Z., Wagner, S. L., Yang, Y., Lamb, B. T., et al. (2009). NSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer disease. J. Clin. Invest. 119, 3692-3702. doi: 10. 1172/JCI39716.
74. Vellas, B., Coley, N., Ousset, P. J., Berrut, G., Dartigues, J. F., Dubois, B., et al. (2012). Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial. Lancet Neurol. 11, 851-859. doi: 10. 1016/S1474-4422(12)70206-5.
75. Venneti, S., Wiley, C. A., and Kofler, J. (2009). Imaging microglial activation during neuroinflammation and Alzheimer's disease. J. Neuroimmune Pharmacol. 4, 227-243. doi: 10. 1007/s11481-008-9142-2.
76. Verkhratsky, A., and Kirchhoff, F. (2007). Glutamate-mediated neuronal-glial transmission. J. Anat. 210, 651-660. doi: 10. 1111/j. 1469-7580. 2007. 00734. x.
77. Verkhratsky, A., Olabarria, M., Noristani, H. N., Yeh, C. Y., and Rodriguez, J. J. (2010). Astrocytes in Alzheimer's disease. Neurotherapeutics 7, 399-412. doi: 10. 1016/j. nurt. 2010. 05. 017.
78. Vinet, J., Weering, H. R., Heinrich, A., Kälin, R. E., Wegner, A., Brouwer, N., et al. (2012). Neuroprotective function for ramified microglia in hippocampal excitotoxicity. J. Neuroinflammation 9: 27. doi: 10. 1186/1742-2094-9-27.
79. Vlad, S. C., Miller, D. R., Kowall, N. W., and Felson, D. T. (2008). Protective effects of NSAIDs on the development of Alzheimer disease. Neurology 70, 1672-1677. doi: 10. 1212/01. wnl. 0000311269. 57716. 63.
80. Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., et al. (2001). A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature 414, 212-216. doi: 10. 1038/35102591.
81. Wei, Z. H., He, Q. B., Wang, H., Su, B. H., and Chen, H. Z. (2007). Meta-analysis: the efficacy of nootropic agent Cerebrolysin in the treatment of Alzheimer's disease. J. Neural. Transm. 114, 629-634. doi: 10. 1007/s00702-007-0630-y.
82. Wharton, S. B., O'Callaghan, J. P., Savva, G. M., Nicoll, J. A., Matthews, F., Simpson, J. E., et al. (2009). Population variation in glial fibrillary acidic protein levels in brain ageing: relationship to Alzheimer-type pathology and dementia. Dement. Geriatr. Cogn. Disord. 27, 465-473. doi: 10. 1159/000217729.
83. Xiao, B. G., Bai, X. F., Zhang, G. X., Hojeberg, B., and Link, H. (1996). Shift from anti-to proinflammatory cytokine profiles in microglia through LPS-or IFN-gamma-mediated pathways. Neuroreport 7, 1893-1898. doi: 10. 1097/00001756-199608120-00004.
84. Yan, Q., Zhang, J., Liu, H., Babu-Khan, S., Vassar, R., Biere, A. L., et al. (2003). Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease. J. Neurosci. 23, 7504-7509.